HPV-Related Cancer
HPV-Related Cancer According to the Centers for Disease Control and Prevention (CDC), about 44,000 HPV-associated cancers occur in the U.S each year. . Support ASHA HPV-associated cancers include cancers of…
FDA Approves HPV Vaccine for Adults Over 26
[post_date] On October 5, 2018 the FDA approved use of the Gardasil 9 HPV vaccine in males and females ages 27-45, expanding the previous indication that covered from ages 9-26.…
Study Finds Nearly Half of Men have HPV
Nearly half of males in the United States have genital human papillomavirus (HPV), according to a study published January 19 in JAMA Oncology. HPV is the most common sexually transmitted…
A Cure for HPV? Evaluating HPV Treatment Options
A cure for HPV! Satisfaction guaranteed! No more outbreaks! If you’ve had an HPV diagnosis, you may have seen claims like this in your search for information on the Internet…
FDA Approves 2-dose Regimen for HPV Vaccine
On October 12th the Food and Drug Administration (FDA) approved a 2-dose schedule for Merck’s Gardasil-9® HPV vaccine for males and females ages 9-14. The new schedule calls for the…
Podcast: HPV FAQs
Most sexually active individuals are estimated to have one or more infections in their lifetime with the human papillomavirus (HPV) and, not surprisingly, ASHA receives countless HPV questions: What should…
HPV: Resources for Healthcare Providers
Why I Vaccinate: Maria Trent, MD, MPH, Associate Professor in Pediatrics at Johns Hopkins Bloomberg School of Public Health, advocates for creating an "HPV-free zone" through vaccination. Dr. Trent speaks…
Podcast: All about HPV with Ina Park, MD
Human papillomavirus, or HPV, is a common sexually transmitted infection. So common that most (~80%) of sexually active people will be infected with HPV at some point. While it is…